A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis

NCT03932006 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Fengshigutong Capsule plus Imrecoxib
DRUG: Fengshigutong Capsule
DRUG: Imrecoxib

Sponsor

Sun Yat-sen University